Original ResearchPublished 12 October 2026Exploring the protective mechanism of Huangqishengmaiyin against anthracycline-induced cardiotoxicity in breast cancer with concomitant gut microbiota modulationYixuan Wang · Yeying Jin · Jiali Han · Mingjia Ding · Haoqing Hou · Miaoyu Mei · Rui YangFrontiers in Cardiovascular Medicinedoi 10.3389/fcvm.2026.1818551
Systematic ReviewPublished 9 October 2026Efficacy of beta-blockers in preventing cardiotoxicity in breast cancer patients receiving anthracyclines: a GRADE-assessed systematic review and meta-analysis with trial sequential analysisVictor M. Samperio · Lorena M. Murrieta Bruciaga · Jesús Antonio Castañeda Martínez · Vanessa Coronado Porchas · Alejandro Chen Liang · Yeison Cruz Castillo · Aishwarya Ghonge · Aishwarya Saripalli · Thomas SchulzFrontiers in Cardiovascular Medicinedoi 10.3389/fcvm.2026.1926758
Original ResearchPublished 8 October 2026Integrated hs-cTnI, global longitudinal strain, and coronary artery calcium for risk stratification of anthracycline-related cardiac dysfunction in multiple myelomaXueshan Zhang · Zongliang YuFrontiers in Cardiovascular Medicinedoi 10.3389/fcvm.2026.1830462
